Dyadic International, Inc. (DYAI)
NASDAQ: DYAI · Real-Time Price · USD
0.7849
+0.0029 (0.37%)
At close: Jun 22, 2026, 4:00 PM EDT
0.7800
-0.0049 (-0.62%)
After-hours: Jun 22, 2026, 4:10 PM EDT
Dyadic International Market Cap
Dyadic International has a market cap or net worth of $28.6 million as of June 22, 2026. Its market cap has decreased by -2.05% in one year.
Market Cap
28.60M
Enterprise Value
28.05M
1-Year Change
-2.05%
Ranking
Category
Stock Price
$0.78
Market Cap Chart
Since April 18, 2019, Dyadic International's market cap has decreased from $94.80M to $28.60M, a decrease of -69.83%. That is a compound annual growth rate of -15.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 22, 2026 | 28.60M | -15.88% |
| Dec 31, 2025 | 34.00M | -34.36% |
| Dec 31, 2024 | 51.80M | 11.64% |
| Dec 29, 2023 | 46.40M | 32.19% |
| Dec 30, 2022 | 35.10M | -72.34% |
| Dec 31, 2021 | 126.90M | -14.20% |
| Dec 31, 2020 | 147.90M | 4.89% |
| Dec 31, 2019 | 141.00M | 48.73% |
| Apr 18, 2019 | 94.80M | - |
View and export this data all the way back to 2019. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NanoViricides | 31.89M |
| Serina Therapeutics | 31.29M |
| Senti Biosciences Holdings | 29.02M |
| Plus Therapeutics | 28.91M |
| NeuroSense Therapeutics | 28.44M |
| Lite Strategy | 28.17M |
| Vistagen Therapeutics | 27.50M |
| IGC Pharma | 27.16M |